AU3065892A - Pneumococcal fimbrial protein a vaccines - Google Patents

Pneumococcal fimbrial protein a vaccines

Info

Publication number
AU3065892A
AU3065892A AU30658/92A AU3065892A AU3065892A AU 3065892 A AU3065892 A AU 3065892A AU 30658/92 A AU30658/92 A AU 30658/92A AU 3065892 A AU3065892 A AU 3065892A AU 3065892 A AU3065892 A AU 3065892A
Authority
AU
Australia
Prior art keywords
vaccines
fimbrial protein
pneumococcal fimbrial
pneumococcal
protein
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU30658/92A
Inventor
Steven P O'Connor
Harold Russell
Jacquelyn Sampson
Jean A Tharpe
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
US Department of Health and Human Services
Original Assignee
US Department of Health and Human Services
US Government
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by US Department of Health and Human Services, US Government filed Critical US Department of Health and Human Services
Publication of AU3065892A publication Critical patent/AU3065892A/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/12—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria
    • C07K16/1267—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-positive bacteria
    • C07K16/1275—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-positive bacteria from Streptococcus (G)
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/315—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Streptococcus (G), e.g. Enterococci
    • C07K14/3156—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Streptococcus (G), e.g. Enterococci from Streptococcus pneumoniae (Pneumococcus)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
AU30658/92A 1991-11-14 1992-11-16 Pneumococcal fimbrial protein a vaccines Abandoned AU3065892A (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US79137791A 1991-09-17 1991-09-17
US791377 1991-11-14
US81628692A 1992-01-03 1992-01-03
US816286 1997-03-13

Publications (1)

Publication Number Publication Date
AU3065892A true AU3065892A (en) 1993-06-15

Family

ID=27121152

Family Applications (1)

Application Number Title Priority Date Filing Date
AU30658/92A Abandoned AU3065892A (en) 1991-11-14 1992-11-16 Pneumococcal fimbrial protein a vaccines

Country Status (2)

Country Link
AU (1) AU3065892A (en)
WO (1) WO1993010238A1 (en)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5928900A (en) * 1993-09-01 1999-07-27 The Rockefeller University Bacterial exported proteins and acellular vaccines based thereon
WO1995016711A1 (en) * 1993-12-17 1995-06-22 Universidad De Oviedo Antibodies against pneumolysine and their applications
AU3584897A (en) * 1996-06-21 1998-01-07 Virginia Commonwealth University Vaccine to prevent streptococcal endocarditis
US5882871A (en) * 1996-09-24 1999-03-16 Smithkline Beecham Corporation Saliva binding protein
US5928895A (en) * 1996-09-24 1999-07-27 Smithkline Beecham Corporation IgA Fc binding protein
US5882896A (en) * 1996-09-24 1999-03-16 Smithkline Beecham Corporation M protein
EP1770164B1 (en) 1996-10-31 2010-09-01 Human Genome Sciences, Inc. Streptococcus pneumoniae antigens and vaccines
US6676943B1 (en) 1997-04-24 2004-01-13 Regents Of The University Of Minnesota Human complement C3-degrading protein from Streptococcus pneumoniae
PT1053329E (en) * 1998-02-03 2010-01-04 Ct Disease Contr & Prevention Recombinant lipidated psaa protein, methods of preparation and use
BR9908476A (en) * 1998-03-02 2000-12-05 Us Health Peptide, therapeutic composition, and, process to confer protective immunity to a patient, against s infection. pneumoniae
US6903184B1 (en) 1998-03-02 2005-06-07 The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services Multiple antigenic peptides immunogenic against Streptococcus pneumonia

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4762713A (en) * 1983-07-05 1988-08-09 The University Of Rochester Boosting of immunogenic conjugate vaccinations by unconjugated bacterial capsular polymers
FR2581877B1 (en) * 1985-05-14 1987-12-18 Louvain Universite Catholique CONJUGATE CONSISTING OF A WALL ADHESIN OF S. MUTANS, OF PROTEIN NATURE AND OF A POLYSACCHARIDE OF S. MUTANS, ITS PREPARATION AND ITS USE IN PARTICULAR IN CARIES VACCINES
GB8924438D0 (en) * 1989-10-31 1989-12-20 Hoffmann La Roche Vaccine composition

Also Published As

Publication number Publication date
WO1993010238A1 (en) 1993-05-27

Similar Documents

Publication Publication Date Title
US5182109C1 (en) Vaccine preparation comprising a bacterial toxin adjuvant
AU4589289A (en) Synthetic antigens, a process for the preparation thereof and the use thereof
ZA922011B (en) Vaccine
CZ197595A3 (en) Vaccine preparations
AU1873292A (en) Blood bag for lyophilization
AU3247093A (en) Flea midgut-supernatant vaccines
AU8326591A (en) Bag valve
AU2699192A (en) Enhanced immunogenicity using leukotoxin chimeras
AP9100332A0 (en) Vaccines
AU3429389A (en) Fish vaccine comprising a virulent, invasive bacterium
AU3065892A (en) Pneumococcal fimbrial protein a vaccines
AU2993492A (en) Improved neck
GB9201139D0 (en) Synthetic peptides for a rubella vaccine
AU3326589A (en) A synthetic vaccine against foot and mouth disease and a process for the preparation thereof
AU5717990A (en) Magnetic protein conjugates, a process for the preparation thereof and the use thereof
AU1270592A (en) Modified interleukin-1beta
AU3092992A (en) A buffer
AU3093092A (en) A buffer
AU3048689A (en) Immunogenic peptides
AU1346092A (en) Angiogenic peptides
IL90833A0 (en) Immunogenic peptide
AU2562692A (en) Head
AU1968392A (en) Infusion bag
ZA896372B (en) Vaccine
AU1851392A (en) Ccv vaccine